Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors

A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Journal of the American Medical Association · 1909 · 7.9K citations · Full text

Medicine, Neurology, Oncology +6

Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease

N. Bodick, Walter Offen, Allan I. Levey et al. · Archives of Neurology · 1997 · 685 citations

Medicine, Neurology, Pharmacology +17

Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia

Anantha Shekhar, William Z. Potter, Jeffrey Lightfoot et al. · American Journal of Psychiatry · 2008 · 559 citations

Medicine, Pharmacology, Psychiatry +17

Selective activation of the M ₁ muscarinic acetylcholine receptor achieved by allosteric potentiation

Lei Ma, Matthew A. Seager, Marion Wittmann et al. · Proceedings of the National Academy of Sciences · 2009 · 284 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.

Shannon He, Bymaster Fp, Calligaro Do et al. · PubMed · 1994 · 164 citations

Medicine, Medicinal Chemistry, Pharmacology +15